ICMR, Sun Pharma in talks to collaborate on clinical research

The Indian Council of Medical Research (ICMR), the apex body for the formulation, coordination and promotion of biomedical research, is in talks with Indian drug major Sun Pharma to create a structure to fund Clinical research in the country.

An ICMR-Sun Pharma joint working group met recently to discuss ways to improve heathcare innovations in the country by conducting disease burden studies and clinical trials in well-characterised sites, which have a high burden of specific diseases as well as healthcare facilities and experts who could diagnose, treat and monitor patients over time.

The group is considering a hub-and-spoke model of clinical trial and research sites as well as specialised laboratories, said a senior official of Sun Pharma. Infectious diseases like dengue and TB are high on the group’s priority list.

The working group is also considering to set up a central unit linked to ICMR to manage the “well-characterised sites, distributed across the country based on the burden of the disease being studied, he said.

The project may require Rs 6 crore-Rs 40 crore in funding. The joint working group is also expected to put together a policy paper by the time it meets again in March 2017 and will seek inputs on it from academicians and the industry, the official said.


Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video